# Commission Regulation (EC) No 1838/97 of 24 September 1997 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance), Annex Extent: E+W+S+N.I. The Annexes to Regulation (EEC) No 2377/90 are hereby amended as follows: A.. Annex I is amended as follows: 1.. Anti-infectious agents 1.1. Chemotherapeutics 1.1.2. Diamino pyrimidine derivates Pharmacologically active substance Marker residue Animal species MRLs Target tissues Other provisions ‘1.1.2.1. Baquiloprim Baquiloprim Bovine 10 μg/kg Fat 300 μg/kg Liver 150 μg/kg Kidney 30 μg/kg Milk Porcine 40 μg/kg Skin + fat 50 μg/kg Liver, kidney’ 1.2. Antibiotics 1.2.4. Macrolides Pharmacologically active substance Marker residue Animal species MRLs Target tissues Other provisions ‘1.2.4.3. Tylosin Tylosin A Bovine 100 μg/kg Muscle, fat, liver, kidney 50 μg/kg Milk Porcine 100 μg/kg Muscle, skin + fat, liver, kidney Poultry 100 μg/kg Muscle, skin + fat, liver, kidney Not for use in hens producing eggs for human consumption’ 4.. Anti-inflammatory agents 4.1. Nonsteroidal anti-inflammatory agents 4.1.2. Fenamate group derivatives Pharmacologically active substance Marker residue Animal species MRLs Target tissues Other provisions ‘4.1.2.1. Tolfenamic acid Tolfenamic acid Bovine 50 μg/kg Muscle 400 μg/kg Liver 100 μg/kg Kidney 50 μg/kg Milk Porcine 50 μg/kg Muscle 400 μg/kg Liver 100 μg/kg Kidney’ B.. Annex II is amended as follows: 1.. Inorganic compounds Pharmacologically active substance(s) Animal species Other provisions ‘1.30. Bismuth subcarbonate All food-producing species For oral use only 1.31. Bismuth subgallate All food-producing species For oral use only 1.32. Bismuth subnitrate All food-producing species For oral use only 1.33. Bismuth subsalicylate All food-producing species For oral use only’ 2.. Organic compounds Pharmacologically active substance(s) Animal species Other provisions ‘2.79. Cloprostenol Bovine, porcine, equidae 2.80. R-Cloprostenol Bovine, porcine, equidae 2.81. Luprostiol All mammalian species’ C.. Annex III is amended as follows: 1.. Anti-infectious agents 1.2. Antibiotics 1.2.5. Aminoglycosides Pharmacologically active substance Marker residue Animal species MRLs Target tissues Other provisions ‘1.2.5.7. Apramycin Apramycin Bovine 1 000 μg/kg Muscle, fat For use in non-lactating cattle only Provisional MRLs expire on 1. 7. 1999 10 000 μg/kg Liver 20 000 μg/kg Kidney Porcine 1 000 μg/kg Muscle, skin + fat, liver Provisional MRLs expire on 1. 7. 1999’ 5 000 μg/kg Kidney --- Source: https://www.legislation.gov.uk/eur/1997/1838/annex (the official version) Page: https://openlegislation.uk/eu-regulation-1997-1838/annex Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.